Učitavanje...
A Phase I Study of Oral Lenalidomide in Patients with Refractory Metastatic Cancer
Objectives of this study were to determine the maximum tolerated dose and to characterize the side-effect profile and pharmacokinetics of lenalidomide in patients with advanced refractory solid tumors. Patients were treated on a modified Fibronacci dose-escalation scheme with an oral daily dose of l...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2009
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2808857/ https://ncbi.nlm.nih.gov/pubmed/19451403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0091270009335001 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|